PDCD1 and neoplasm: In NSCLC, PD-L1 expression reported as the percentage of viable tumor cells showing membranous staining for PD-L1 at immunohistochemistry (tumor proportion score, TPS) is a predictive biomarker of response to ICIs targeting PD-1 or PD-L1.